In a subsequent nested case-control study that analyzed a DCIS cohort treated with BCS without RT, invasive-IBR was associated with palpability, young age, and the expression of p16, COX-2, and Ki-67 (27). The gene discussed is MKI67; the disease is ductal breast carcinoma in situ.